Contemporary radiotherapy: present and future

被引：255

作者：

Chandra, Ravi A. ^{[1
]}

Keane, Florence K. ^{[2
]}

Voncken, Francine E. M. ^{[3
]}

Thomas, Charles R., Jr. ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Radiat Med, Portland, OR 97239 USA

[2] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA

[3] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands

来源：

LANCET | 2021年 / 398卷 / 10295期

关键词：

SQUAMOUS-CELL CARCINOMA; LONG-TERM OUTCOMES; STEREOTACTIC ABLATIVE RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; INVASIVE BLADDER-CANCER; NO AXILLARY DISSECTION; EARLY BREAST-CANCER; 20-YEAR FOLLOW-UP; LUNG-CANCER; RADIATION-THERAPY;

D O I：

10.1016/S0140-6736(21)00233-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Oncology care is increasingly a multidisciplinary endeavour, and radiation therapy continues to have a key role across the disease spectrum in nearly every cancer. However, the field of radiation oncology is still one of the most poorly understood of the cancer disciplines. In this Review, we attempt to summarise and contextualise developments within the field of radiation oncology for the non-radiation oncologist. We discuss advancements in treatment technologies and imaging, followed by an overview of the interplay with advancements in systemic therapy and surgical techniques. Finally, we review new frontiers in radiation oncology, including advances within the metastatic disease continuum, reirradiation, and emerging types of radiation therapy.

引用

页码：171 / 184

页数：14

共 133 条

[1] Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].

Ang, K. Kian ;

Harris, Jonathan ;

Wheeler, Richard ;

Weber, Randal ;

Rosenthal, David I. ;

Nguyen-Tan, Phuc Felix ;

Westra, William H. ;

Chung, Christine H. ;

Jordan, Richard C. ;

Lu, Charles ;

Kim, Harold ;

Axelrod, Rita ;

Silverman, C. Craig ;

Redmond, Kevin P. ;

Gillison, Maura L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35

[2] Extent and kinetics of recovery of occult spinal cord injury [J].

Ang, KK ;

Jiang, GL ;

Feng, Y ;

Stephens, LC ;

Tucker, SL ;

Price, RE .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (04) :1013-1020

[3] Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer (vol 368, pg 2385, 2013) [J].

不详 .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (16) :1582-1582

[4] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Kurata, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

Carpeno, J. de Castro ;

Faivre-Finn, C. ;

Reck, M. ;

Vansteenkiste, J. ;

Spigel, D. R. ;

Wadsworth, C. ;

Melillo, G. ;

Taboada, M. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350

[5] Expanding global access to radiotherapy [J].

Atun, Rifat ;

Jaffray, David A. ;

Barton, Michael B. ;

Bray, Freddie ;

Baumann, Michael ;

Vikram, Bhadrasain ;

Hanna, Timothy P. ;

Knaul, Felicia M. ;

Lievens, Yolande ;

Lui, Tracey Y. M. ;

Milosevic, Michael ;

O'Sullivan, Brian ;

Rodin, Danielle L. ;

Rosenblatt, Eduardo ;

Van Dyk, Jacob ;

Yap, Mei Ling ;

Zubizarreta, Eduardo ;

Gospodarowicz, Mary .

LANCET ONCOLOGY, 2015, 16 (10) :1153-1186

[6] Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial [J].

Ball, David ;

Mai, G. Tao ;

Vinod, Shalini ;

Babington, Scott ;

Ruben, Jeremy ;

Kron, Tomas ;

Chesson, Brent ;

Herschtal, Alan ;

Vanevski, Marijana ;

Rezo, Angela ;

Elder, Christine ;

Skala, Marketa ;

Wirth, Andrew ;

Wheeler, Greg ;

Lim, Adeline ;

Shaw, Mark ;

Schofield, Penelope ;

Irving, Louis ;

Solomon, Benjamin .

LANCET ONCOLOGY, 2019, 20 (04) :494-503

[7] Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012 [J].

Barton, Michael B. ;

Jacob, Susannah ;

Shafiq, Jesmin ;

Wong, Karen ;

Thompson, Stephen R. ;

Hanna, Timothy P. ;

Delaney, Geoff P. .

RADIOTHERAPY AND ONCOLOGY, 2014, 112 (01) :140-144

[8] Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications [J].

Batumalai, Vikneswary ;

Delaney, Geoff P. ;

Descallar, Joseph ;

Gabriel, Gabriel ;

Wong, Karen ;

Shafiq, Jesmin ;

Barton, Michael .

RADIOTHERAPY AND ONCOLOGY, 2020, 152 :70-77

[9]

Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118

[10]

Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7

← 1 2 3 4 5 6 7 8 9 10 →